Clinical Trial Update: Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713 [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety, tolerability, and pharmacokinetics of KN510 and KN713 in patients with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• KN510 (KN510)
• KN713 (KN713)

Snippet

Sponsor: New Cancer Cure-Bio Co.,Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED